Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-02

Clinical Trial Update: Genetic Studies of X-linked Lymphoproliferative Disease

View source ↗

Summary

This clinical trial update reports on completed genetic studies of X-linked lymphoproliferative disease (XLP). The study, sponsored by NIAID, explored genetic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: X-Linked Lymphoproliferative Disease, Lymphoproliferative Disease | Status: COMPLETED